Add to ORKGSponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Objective. To determine whether intratympanic (IT) dexa-methasone ameliorates cisplatin-induced ototoxicity in a mouse model of presbycusis
Clinical ototoxicity—permanent hearing loss caused by medications—is estimated to affect millions of...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Sponsorships or competing interests that may be relevant to content are dis-closed at the end of thi...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
PubMed: 31569969Ototoxicity is the general name of cochlear and vestibular organ injury resulting fr...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
SIMSEK, GOKCE/0000-0001-5281-0986WOS: 000496697400005PubMed: 31531774Purpose The main aim of this st...
Cisplatin ototoxicity is a major dose-limiting factor in the treatment of several neoplasms. Dexamet...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
Background: Cisplatin is a commonly used anti-cancer drug. However, its use is associated with sever...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
Objective: We investigated the otoprotective effect of methylprednisolone against cisplatin-induced ...
Clinical ototoxicity—permanent hearing loss caused by medications—is estimated to affect millions of...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Sponsorships or competing interests that may be relevant to content are dis-closed at the end of thi...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
PubMed: 31569969Ototoxicity is the general name of cochlear and vestibular organ injury resulting fr...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
SIMSEK, GOKCE/0000-0001-5281-0986WOS: 000496697400005PubMed: 31531774Purpose The main aim of this st...
Cisplatin ototoxicity is a major dose-limiting factor in the treatment of several neoplasms. Dexamet...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
Background: Cisplatin is a commonly used anti-cancer drug. However, its use is associated with sever...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
Objective: We investigated the otoprotective effect of methylprednisolone against cisplatin-induced ...
Clinical ototoxicity—permanent hearing loss caused by medications—is estimated to affect millions of...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...